NRC · Nrc Health
Market Cap
$476.23M
Shares
22.12M
NRC metrics
94 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$21.53
Market cap
$476.23M
Price action
19 metricsPrice change (1W)
-1.5%
Price change (30D)
+3.0%
Price change (3M)
+12.5%
Price change (6M)
+47.6%
Price change (YTD)
+14.7%
Price change (1Y)
+43.9%
Trailing year
Price change (5Y)
-59.6%
52-week high
$22.77
52-week low
$11.42
Change from 52-week high
-5.4%
Change from 52-week low
+88.5%
Annualized volatility
57.4%
Beta
0.6
RSI (14D)
53.0
Price vs SMA 50
+1.3%
Price vs SMA 200
+16.0%
Avg volume (3M)
127,018
Relative volume
1.1
Average dollar volume
$2.63M
Company
3 metricsSector
Healthcare
Industry
Health Information Services
Shares outstanding
22.12M
Valuation
12 metricsP / E (TTM)
0.4
Trailing earnings · reciprocal yield 231.1%
PEG ratio
0.0
EV / revenue
4.0×
reciprocal yield 24.9%
EV / EBITDA
24.1×
reciprocal yield 4.2%
EV / EBIT
38.2×
reciprocal yield 2.6%
P / sales
3.4×
reciprocal yield 29.4%
P / book
72.7
reciprocal yield 1.4%
FCF yield
4.5%
TTM · current market cap
Buyback yield
4.0%
P / FCF
22.0
reciprocal yield 4.5%
P / operating cash flow
16.1
reciprocal yield 6.2%
Earnings yield
1.2%
Historical valuation
8 metricsP / E historical average (3Y)
29.6×
reciprocal yield 3.4%
P / E historical average (5Y)
29.3×
reciprocal yield 3.4%
EV / revenue historical average (3Y)
4.4×
reciprocal yield 22.5%
EV / revenue historical average (5Y)
5.6×
reciprocal yield 18.0%
EV / EBIT historical average (3Y)
19.1×
reciprocal yield 5.2%
EV / EBIT historical average (5Y)
20.3×
reciprocal yield 4.9%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
2.8%
Trailing 12 months
Payout ratio
216.9%
Shareholder yield
6.6%
Dividend / share (TTM)
$0.60
Dividend growth YoY
+25.0%
Dividend growth streak
1
Last ex-dividend
2026-06-26
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-07-28
Profitability
9 metricsGross margin
—
Operating margin
10.5%
Trailing 12 months
Net margin
4.2%
Gross profit (TTM)
—
Operating profit (TTM)
$14.74M
Net income (TTM)
$5.86M
Trailing 12 months
Diluted EPS (TTM)
$49.75
FCF margin
15.5%
Effective tax rate
37.6%
Growth
11 metricsRevenue growth YoY
+4.0%
Year over year
Net income growth YoY
-53.2%
Revenue (TTM)
$140.00M
Trailing 12 months
EPS growth YoY
+4,707.7%
Shares change YoY
-2.9%
Year over year · fewer shares
Revenue CAGR (3Y)
-3.2%
Revenue CAGR (5Y)
+0.6%
EPS CAGR (3Y)
+240.2%
EPS CAGR (5Y)
+103.0%
FCF CAGR (3Y)
-15.9%
FCF CAGR (5Y)
-15.5%
Quality
14 metricsReturn on equity
89.4%
Return on assets
4.3%
Debt / equity
13.7
Current ratio
0.7
EBITDA (TTM)
$23.37M
Free cash flow (TTM)
$21.64M
Quick ratio
0.7
Interest coverage
2.7
Net debt / EBITDA
3.7
Return on invested capital
9.9%
Trailing 12 months
Net cash
−$86.70M
Latest balance sheet
Cash & equivalents
$3.33M
Total assets
$136.15M
Total debt
$90.03M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$29.51M
Capital expenditures (TTM)
$7.87M
R&D (TTM)
—
SG&A (TTM)
$63.08M
Stock compensation (TTM)
$11.81M
R&D / revenue
—
Stock compensation / revenue
8.4%
Ownership (13F)
3 metrics13F filers
125
13F filer change QoQ
+3
Institutional ownership
48.7%
Short interest
3 metricsShort interest
2.5%
Latest settlement · 4.4 days to cover
Days to cover
4.4d
Short-squeeze score
57 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—